HMME

Jia Zhang1,2, Chunyu Lai1, Bin Li1

  • 1Department of Medical Oncology, The First Affiliated Hospital, School of Medicine, Zhejiang University, #79 Qingchun Road, Hangzhou, 310003, China.

PubMed
概括

这项研究开发了一种载有血红素单甲基乙烯 (HMME) 的乳液水凝,以增强难以治疗的癌症的声动力免疫疗法. 这种新型的水凝增强了抗瘤免疫反应,并与免疫检查点阻塞疗法相结合,提高了治疗效率.